Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01300065 · ClinicalTrials.gov registry record · NA
Evaluation of Two Daily Disposable Contact Lenses.
A NA study of Myopia, sponsored by Bausch & Lomb Incorporated.
- Completed
- Registry status
- NA
- Development phase
- 441
- Enrollment target
- 1
- Study location
NCT01300065: Completed NA study of Myopia, sponsored by Bausch & Lomb Incorporated.
NCT01300065 is a NA study of Myopia that has completed, run by Bausch & Lomb Incorporated. The registered enrollment target is 441 participants, above the 263-participant average among 90 other Myopia trials with a reported enrollment target (68% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01300065, a NA study of Myopia, has completed, sponsored by Bausch & Lomb Incorporated.
- COMPLETED
- Registry status
- NA
- Development phase
- 441 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this clinical study is to evaluate the product performance of SofLens daily disposable contact lenses packaged in the investigational Test solution versus SofLens daily disposable contact lenses packaged in Control, solution as it relates to comfort when used by subjects who use technology devices (eg, Personal Digital Assistants \[PDAs\], computers, electronic game consoles, hand-held electronic devices, electronic book readers, etc) on an average of 4 hours per day over a week's time for a minimum of 4 days each week.
Primary Outcome
Graded slit lamp findings for each eye, including epithelial edema, epithelial microcysts, corneal staining, limbal and bulbar injections, upper lid tarsal conjunctival abnormalities, corneal neovascularization, and corneal infiltrates were graded for severity on a scale from 0 (No Finding) to 4 (Severe Finding). The outcome measure is any finding \> grade 2, across abnormalities.
Conditions Studied
Interventions
- DEVICE Experimental- Soflens
- DEVICE Marketed - Soflens
Study Locations (1)
New York
- Bausch & Lomb Incorporated - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 441 participants |
| Start Date | 2011-01 |
| Est. Completion | 2011-05 |
| Phase | NA |
What the finished NCT01300065 record still lists
NCT01300065 is an interventional study that assigns participants to a tested intervention. The registered 441 participants enrollment target is mid-sized for trials with a published cap, above the 263-participant average among 90 other Myopia trials with a reported enrollment target (68% higher).
The record links to 1 condition, with Myopia appearing as the primary indexed condition, and to 2 interventions - of which Experimental- Soflens is the first listed.
NCT01300065 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT01300065 about?
NCT01300065 is a clinical study titled "Evaluation of Two Daily Disposable Contact Lenses.". The objective of this clinical study is to evaluate the product performance of SofLens daily disposable contact lenses packaged in the investigational Test solution versus SofLens daily disposable contact lenses packaged in Control, solution as it relates to comfort when used by subjects who use tec...
What is the current status of trial NCT01300065?
This trial is currently completed. It is a NA study. The enrollment target is 441 participants. The study started on 2011-01. Estimated completion is 2011-05.
What conditions does trial NCT01300065 study?
This clinical trial studies the following conditions: Myopia.
What interventions are being tested in trial NCT01300065?
The interventions under investigation include: Experimental- Soflens (DEVICE), Marketed - Soflens (DEVICE).
Who is sponsoring clinical trial NCT01300065?
This trial is sponsored by Bausch & Lomb Incorporated, which has 174 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01300065 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01300065's enrollment target sits among peer trials
441 10th of 90 higher than 81 of 90 other Myopia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Myopia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Efficacy of Repeated Low-level Red-light Therapy in Myopia Control
RECRUITING · NA
-
Comprehensive Assessment of Multiple Products (CAMP)
RECRUITING · NA
-
Children's Viewing Behavior
RECRUITING · NA
-
Violet Light for the Suppression of Myopia
RECRUITING · NA
-
Measuring Outcomes of LASIK and EVO-ICL in Matched Populations
RECRUITING · NA
-
Wavelength Intervention for Nearsighted Kids
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02679144 · 441 participants · Phase 2
Neuroblastoma Maintenance Therapy Trial
- NCT03704766 · 442 participants · NA
Alpha-Defensin and Synovial Proteins to Improve Detection of Pediatric Septic Arthritis
- NCT04657068 · 442 participants · Phase 1
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- NCT05410145 · 442 participants · Phase 1
A Study of D3S-001 Monotherapy or Combination Therapy in Subjects With Advanced Solid Tumors With a KRAS p.G12C Mutation
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia